GeneDx Holdings Corp. Marketable Securities (Current)
GeneDx Holdings Corp. (WGS) had Marketable Securities (Current) of $72.23 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-08-03
- 2026-06-30: Marketable Securities, Current $72.23M.
- 2026-03-31: Marketable Securities, Current $76.76M.
- 2025-12-31: Marketable Securities, Current $66.28M.
- 2025-09-30: Marketable Securities, Current $59.11M.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-06-30 | $72.23M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $76.76M 10-Q · filed 2026-05-04 |
| 2025-12-31 | $66.28M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $59.11M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $60.44M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $59.46M 10-Q · filed 2025-04-30 |
| 2024-12-31 | $55.97M 10-K · filed 2026-02-23 |
| 2024-09-30 | $58.57M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $50.78M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $29.24M 10-Q · filed 2024-04-29 |
| 2023-12-31 | $30.47M 10-K · filed 2025-02-20 |
| 2023-09-30 | $26.91M 10-Q · filed 2023-11-03 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |